A digital twin platform enables faster development of high-speed optical computing applications by allowing developers to train and optimize tasks without physical optical hardware access. The platform demonstrates significant acceleration in optimization, reducing development time by 99.4% for certain tasks.
Researchers developed a new method for tracking moving targets using single-photon LiDAR, overcoming the motion-induced temporal-averaging bias. The method, P3DTT, exploits spatiotemporal correlations to identify and use photon events, recovering the target's instantaneous 3D position.
A new programmable silicon photonic neuron enables directional control, addressing a longstanding challenge in photonic neurons. The device can control directionality, feedback and back-action between interconnected components, opening a path toward more adaptable neuromorphic computing systems.
Researchers identify HLA-E as a key regulator of metastasis-initiating hepatocyte states, linked to IFN-γ–JAK–STAT3 pathway. Chronic immune pressure contributes to metastasis initiation in HCC, suggesting a new target for limiting immune-driven metastasis.
Researchers investigated NDUFA11's role in Parkinson's disease, finding it maintains mitochondrial function and integrity. Impaired NDUFA11 function contributes to mitochondrial dysfunction, oxidative stress, and PD-related abnormalities.
A recent study found that TYW5 gene dysregulation is associated with circadian disruption and schizophrenia, affecting locomotor rhythms and prefrontal synaptic ultrastructure. Altering TYW5 expression levels in mice led to changes in behavior, including increased locomotor activity and anxiety-like behavior.
PTHrP inhibits BMP2-induced osteochondral differentiation by inactivating the PI3K–AKT signaling pathway, preserving cartilage phenotype and promoting chondrogenesis. This finding suggests PTHrP's potential application in BMP2-based cartilage tissue engineering.
Researchers have developed a programmable directional photonic spiking neuron based on a non-Hermitian silicon microresonator. The device, called DRUM, can emit spikes in one direction while remaining inactive in the other, reducing unwanted crosstalk and enabling true directional interaction.
This review synthesizes clinical and basic research progress on obesity and CVDs, exploring epidemiology, pathophysiology, and management strategies. The authors highlight the effects of obesity on various CVDs, emphasizing the need for effective prevention and treatment strategies.
The DSTOX platform uses a multi-strategy fusion approach to integrate statistical rule-based models, expert knowledge rule-based models, and analogue search for mutagenicity assessment. The platform achieved an accuracy of 92.0% in internal validation and 84.0% in external validation, comparable to mainstream prediction tools.
Researchers from Zhejiang University developed a hybrid mode/wavelength division multiplexing transmitter chip using lithium niobate on insulator, achieving an aggregate capacity of 8.64 Tbps. The chip combines six modes and six wavelengths, enabling 36 independent channels with each supporting 240 Gbps transmission.
A new study reveals that the Estrogen–SIRT5–FDX1 axis preserves osteogenesis by inhibiting cuproptosis in mesenchymal stem cells (MSCs). SIRT5 demalonylates ferredoxin 1 (FDX1), reducing cuproptotic signaling and preserving osteogenic differentiation.
Researchers classified liver cancer into three molecular subtypes based on lipid droplet-associated genes, identifying PLIN3 as a key regulator of tumor progression. The study provides insights into metabolic reprogramming and heterogeneity in HCC, offering a framework for personalized prognostic and therapeutic strategies.
Researchers discovered that artesunate targets glucosylceramidase (GBA) to induce apoptosis in HCC, disrupting sphingolipid homeostasis and activating caspase-dependent signaling pathways. GBA inhibition promotes α-syn accumulation, impairing CTSD maturation and triggering mitochondrial apoptosis.
A recent study found that monocyte-derived IL-1β promotes CRC progression by activating a positive feedback loop driving EMT, tumor growth, and metastasis. The p65-KRT7-ILK axis is identified as a key regulator of CRC progression.
Researchers found that OSKTF-mediated neuronal rejuvenation boosts rehabilitation-driven corticospinal tract (CST) repair after ischemic stroke. The study demonstrated that combining OSKTF expression with rehabilitative training significantly enhances CST axon sprouting and skilled locomotor function recovery.
A new study uses spatial transcriptomics to map the molecular evolution of prostate cancer and identifies key genes associated with disease progression. The research reveals that genetic malignancy in specific glandular epithelial regions tightly aligns with increasing clinical Gleason scores.
Researchers developed a novel parallel-risk framework to optimize precision transplantation for pediatric patients with acute myeloid leukemia. The framework successfully identifies which patients will benefit from stem cell transplantation directly at diagnosis, overcoming diagnostic biases and subjective clinical assessments.
Piezo ion channels regulate gastrointestinal motility, secretion, barrier integrity, immune responses, and cancer progression. Dysregulation of these channels is associated with various digestive diseases, including hepatocellular carcinoma, gastric cancer, and colorectal cancer.
Purinergic signaling plays a crucial role in osteoarthritis progression, influencing joint inflammation, cartilage degeneration, and chronic pain. Targeting specific receptor pathways offers new opportunities for targeted therapies.
T cell exhaustion plays a complex role in organ transplantation, promoting both graft tolerance and vulnerabilities to infection and malignancy. The review explores the molecular mechanisms underlying exhaustion and discusses emerging strategies to intentionally induce or modulate it as a therapeutic tool.
A growing understanding of trained immunity is reshaping how scientists view diabetes and its many complications. Factors commonly associated with diabetes can activate trained immunity pathways, promoting insulin resistance and accelerating damage throughout the body.
Autophagy plays a central role in gastric cancer cell survival and treatment response to cisplatin. Controlling autophagy could make cancer cells more vulnerable to chemotherapy.
Excess body fat promotes chronic inflammation, telomere shortening, mitochondrial dysfunction, and other age-related changes, accelerating the aging process. Weight loss interventions and anti-obesity therapies may partially reverse these changes, improving metabolic function and reducing biological markers linked to aging.
A growing understanding of RNA biology reveals that N6-methyladenosine (m6A) is a key regulator of nervous system development and a potential contributor to neurological damage caused by toxic environmental exposures. Disruptions in m6A regulation have been linked to various neurodegenerative diseases, including Alzheimer's, Parkinson'...
Researchers explore ferroptosis as a promising strategy to treat prostate cancer. Ferroptosis is a distinct form of regulated cell death that occurs when there is excessive accumulation of reactive oxygen species and oxidative damage to polyunsaturated fatty acid-containing membrane lipids.
Tumors expressing POU2F3, a tuft cell master regulator, represent a distinct molecular class of 'tuft cell-like' cancers. These tumors exhibit unique biological characteristics that may create new opportunities for diagnosis and targeted therapy.
Emerging evidence suggests that Fabry disease involves a complex network of biological disturbances, including oxidative stress, inflammation, and mitochondrial dysfunction. New findings highlight the importance of kidney podocyte injury, disrupted energy metabolism, and immune cell involvement in organ damage.
Scientists discover PIWI proteins and piRNAs play key role in controlling stem cells' identity, repair tissues, and develop specialized cell types through epigenetic regulation. The pathway has potential as both biomarker and therapeutic target for treating diseases such as cancer, bone disorders, and neurodegenerative conditions.
Ménière’s disease is a complex inner ear disorder with diverse symptoms, influenced by genetic susceptibility, immune dysfunction, viral infection, inflammation, and ion regulation. A new review proposes the endolymphatic sac as a central site where multiple factors converge, leading to endolymphatic hydrops and disease progression.
Researchers have gained a deeper understanding of how autophagy and ferroptosis interact to disrupt cellular balance and contribute to the development of complications. This knowledge positions these processes as central components in the evolving landscape of diabetes care, offering a more integrated view of disease and recovery.
The enzyme HMGCR plays a central role in cholesterol biosynthesis, supporting tumor growth by enhancing cell proliferation and enabling metastasis. Inhibiting its activity can disrupt the supply of cholesterol and related molecules that tumors rely on, leading to reduced tumor growth and increased sensitivity to treatment.
The dynamic relationship between nerves and tumors reveals a complex tumor microenvironment that includes neural networks. Signals from the peripheral nervous system can directly influence cancer cell proliferation, metastasis, and treatment resistance.
The review highlights how long non-coding RNAs (lncRNAs) may help bridge the critical gap in diagnosing and treating liver cancer linked to hepatitis B. LncRNAs, once overlooked molecules, are now recognized as powerful regulators of cellular activity influencing gene expression and immune responses.
Advances in CRISPR-Cas9 gene editing and epigenetic modification are revolutionizing disease prevention by enabling earlier detection of risk and more precise intervention at the genetic level. These technologies hold promise for preventing inherited conditions and chronic illnesses, and may ultimately lead to personalized medicine.
Selenoproteins, tiny proteins built with selenocysteine, play a significant role in protecting cells from damage, regulating metabolism, and guiding life-and-death decisions. They manage oxidative stress, supporting antioxidant defense systems and maintaining redox balance.
A growing body of scientific insight is transforming how cancer treatment resistance is understood, highlighting lactylation as a key regulatory mechanism. This emerging perspective points to new opportunities for more precise and effective interventions.
FOXO2 is a key transcription factor that coordinates pancreatic development, maintains islet cell identity, and regulates glucose homeostasis. It drives pancreatic organogenesis, guiding the formation and specialization of endocrine cells within the pancreas.
Tumors harbor complex communities of bacteria, fungi, and viruses that influence disease progression and immune responses. These microbial populations can either promote or suppress cancer growth, underscoring their dual role in oncology.
The MYH9 gene encodes non-muscle myosin IIA, essential for cell movement, division, and signal transmission. Emerging therapeutic strategies target MYH9, potentially improving treatment outcomes in various malignancies.
Emerging knowledge highlights FOXK2's versatile transcription factor function in shaping cancer behavior, with varying expression levels observed across cancers. Its dynamic activity positions FOXK2 as a critical factor in understanding tumors' growth, adaptation, and response to treatment.
Megalain plays a central role in maintaining cellular balance, organ function, and human health through nutrient transport, neuroprotection, and receptor-mediated endocytosis. Its involvement in drug interactions and toxic responses highlights the need for precise therapeutic strategies.
Research highlights cellular senescence as a key driver of intervertebral disc degeneration and chronic low back pain. Senescent cells release inflammatory signals that accelerate tissue breakdown and impair repair processes.
The article highlights Lgr6 as a central regulator of tissue repair and disease development, with its presence linked to stem cell markers and influential signaling pathways. Abnormal expression of Lgr6 is observed in various diseases, including cancer, and is associated with disease severity and treatment response.
Dendritic cell vaccines are engineered to carry tumor-associated antigens, stimulating cytotoxic T lymphocytes to attack malignant cells while sparing healthy tissue. These vaccines have the potential to amplify immune activation and overcome tumor-induced immunosuppression when paired with other therapies.
CircRNAs are emerging as powerful regulators of cellular processes, influencing mechanisms such as oxidative stress, apoptosis, and DNA damage. They interact with key biological pathways to shape outcomes in cardiotoxicity, nephrotoxicity, neurotoxicity, and gastrointestinal injury.
CXorf67, a protein regulating gene activity and DNA repair processes, has been linked to several cancer types including brain tumors, osteosarcoma, and lung cancer. Therapeutic strategies targeting CXorf67-related vulnerabilities, such as PARP inhibitors and EZH2 inhibitors, are being explored.
The KCNE gene family acts as key regulators of voltage-gated potassium channels, controlling their activation and ion flow. These subtle disruptions can have widespread consequences on cellular communication and physiological demands.
Research highlights the impact of skewed XCI on disease severity and identifies potential therapeutic approaches, including reactivating genes on the inactive X chromosome. Emerging techniques to measure XCI patterns hold promise for personalized therapies.
Research reveals CUDC-907's therapeutic potential in combating glioblastoma by inhibiting PI3K and HDAC, leading to enhanced TMZ sensitivity through disrupted double-strand break repair pathways.